目的探讨普米克舒令和爱喘乐联合雾化吸入治疗毛细支气管炎临床疗效。方法治疗组常规综合治疗加普米克令舒液0.5 mg和0.025%爱喘乐溶液(0.2 ml或0.4 ml)雾化吸入,对照组采用常规综合治疗加静脉滴注地塞米松和喘定,直至症状消失,对治疗后症状、体征改善时间进行比较。结果治疗组缓解喘憋、缩短哮鸣音持续时间优于对照组(P<0.05)。结论联合雾化吸入普米克令舒和爱喘乐能明显提高毛细支气管炎的疗效,而且起效迅速、安全方便。 Objective To investigate the clinical efficacy of pulmicort respules combined with atrofed inhalation in the treatment of bronchiolitis. Methods The patients in the treatment group were given conventional inhalation of gatifloxacin 0.5 mg and 0.025% atrophy solution (0.2 ml or 0.4 ml), while the control group received conventional combination therapy plus intravenous dexamethasone and asthma until Symptoms disappeared, after treatment, symptoms, signs of improvement time to compare. Results The treatment group relieved wheezing and shortened wheeze duration better than the control group (P <0.05). Conclusion Combined inhalation of pulmicort respules and atrophy can significantly improve the curative effect of bronchiolitis, and the rapid onset and safety and convenience.